|
Volumn 11, Issue 1, 2010, Pages 18-24
|
The mousepox experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIDOFOVIR;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INTERLEUKIN 4;
ADAPTIVE IMMUNITY;
AUSTRALIA;
BIOLOGICAL PEST CONTROL;
BIOLOGICAL WARFARE;
BIOSAFETY;
COEVOLUTION;
DNA SEQUENCE;
ECTROMELIA VIRUS;
GENE INSERTION;
GENETIC ENGINEERING;
GENETIC MANIPULATION;
GENOMICS;
GOVERNMENT REGULATION;
HUMAN;
MEDICAL RESEARCH;
MONKEYPOX VIRUS;
MYXOMA VIRUS;
NATURAL KILLER CELL;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PUBLICATION;
RECOMBINANT DNA TECHNOLOGY;
SMALLPOX;
TRANSGENIC ORGANISM;
VACCINIA VIRUS;
VIRUS ATTENUATION;
VIRUS GENOME;
VIRUS PATHOGENESIS;
VIRUS RECOMBINANT;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
VIRUS VIRULENCE;
ECTROMELIA VIRUS;
|
EID: 74149090195
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.1038/embor.2009.270 Document Type: Note |
Times cited : (19)
|
References (10)
|